These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2521812

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole.
    Grem JL, Fischer PH.
    Cancer Res; 1985 Jul; 45(7):2967-72. PubMed ID: 4005834
    [Abstract] [Full Text] [Related]

  • 6. Increased growth inhibition and DNA lesions in human colon adenocarcinoma cells treated with methotrexate or 5-fluorodeoxyuridine followed by calmodulin inhibitors.
    Lönn U, Lönn S.
    Cancer Res; 1988 Jun 15; 48(12):3319-23. PubMed ID: 2453268
    [Abstract] [Full Text] [Related]

  • 7. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells.
    Zhen YS, Taniki T, Weber G.
    Oncol Res; 1992 Jun 15; 4(2):73-8. PubMed ID: 1596584
    [Abstract] [Full Text] [Related]

  • 8. Biochemical modulation of fluorouracil by dipyridamole: preclinical and clinical experience.
    Grem JL.
    Semin Oncol; 1992 Apr 15; 19(2 Suppl 3):56-65. PubMed ID: 1557658
    [Abstract] [Full Text] [Related]

  • 9. Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2'-deoxyuridine in the HCT-8 human carcinoma line.
    Sobrero AF, Moir RD, Bertino JR, Handschumacher RE.
    Cancer Res; 1985 Jul 15; 45(7):3155-60. PubMed ID: 3159474
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tezacitabine enhances the DNA-directed effects of fluoropyrimidines in human colon cancer cells and tumor xenografts.
    Taverna P, Rendahl K, Jekic-McMullen D, Shao Y, Aardalen K, Salangsang F, Doyle L, Moler E, Hibner B.
    Biochem Pharmacol; 2007 Jan 01; 73(1):44-55. PubMed ID: 17046720
    [Abstract] [Full Text] [Related]

  • 12. Interaction of deoxyuridine with fluorouracil and dipyridamole in a human colon cancer cell line.
    Grem JL, Mulcahy RT, Miller EM, Allegra CJ, Fischer PH.
    Biochem Pharmacol; 1989 Jan 01; 38(1):51-9. PubMed ID: 2462882
    [Abstract] [Full Text] [Related]

  • 13. Modulation of 5-fluorouracil toxicity by uridine, deoxyuridine, orotate and dipyridamole in normal tissues of rats with liver adenocarcinoma.
    el Hag IA, Jakobsson B, Christensson PI, Erichsen C, Jönsson PE, Stenram U.
    In Vivo; 1987 Jan 01; 1(5):309-12. PubMed ID: 2485133
    [Abstract] [Full Text] [Related]

  • 14. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T, Suzuki N, Yamaguchi M, Ohshimo H, Fukushima M.
    Int J Oncol; 2004 Sep 01; 25(3):571-8. PubMed ID: 15289858
    [Abstract] [Full Text] [Related]

  • 15. [Potentiated antitumor effect of methotrexate by dipyridamole].
    Cao SS.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb 01; 11(1):7-12. PubMed ID: 2527632
    [Abstract] [Full Text] [Related]

  • 16. Interaction between 5-fluorouracil and DNA of human colon adenocarcinoma.
    Lönn U, Lönn S.
    Cancer Res; 1984 Aug 01; 44(8):3414-8. PubMed ID: 6430549
    [Abstract] [Full Text] [Related]

  • 17. Differentially potentiating effects by dipyridamole on cytotoxicity of 5-fluorouracil against three human maxillary cancer cell lines derived from a single tumor.
    Sato S, Kohno K, Hidaka K, Hisatsugu T, Kuwano M, Komiyama S.
    Anticancer Drug Des; 1993 Aug 01; 8(4):289-97. PubMed ID: 8240657
    [Abstract] [Full Text] [Related]

  • 18. Modulation of 5-fluorouracil and 5-fluorouridine toxicity by membrane transport inhibitors in normal tissues of rats with liver adenocarcinoma.
    Jakobsson B, el Hag IA, Erichsen C, Christensson PI, Jönsson PE, Stenram U.
    Anticancer Res; 1989 Aug 01; 9(2):285-90. PubMed ID: 2751255
    [Abstract] [Full Text] [Related]

  • 19. Selective cytotoxicity of 5-hydroxyuridine for human colon adenocarcinoma cells.
    Lockshin A, Giovanella BC, Mendoza JT, Warneke C, Stehlin JS.
    Cancer Treat Rep; 1985 Aug 01; 69(7-8):845-50. PubMed ID: 3160461
    [Abstract] [Full Text] [Related]

  • 20. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.
    Glazer RI, Lloyd LS.
    Mol Pharmacol; 1982 Mar 01; 21(2):468-73. PubMed ID: 7099147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.